| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2003 | CN1406583A Usage of indole derivatives for treating tumours |
| 04/02/2003 | CN1406582A Anti-cancer salvithin injection |
| 04/02/2003 | CN1406516A Healthy food |
| 04/02/2003 | CN1104504C Process for preparing amylovorin of sea bacteria |
| 04/02/2003 | CN1104439C Phenyl substituted 4-azasteroidal fluorine derivatives, preparation thereof and pharmaceutical compositions containing them |
| 04/02/2003 | CN1104438C 槲寄生提取物及其用途 Mistletoe extract and use |
| 04/02/2003 | CN1104437C Compound extracted from heroubill herb and its medicinal preparation |
| 04/02/2003 | CN1104436C Vinyl pyrrolidine cephalosporins with basic substituents |
| 04/02/2003 | CN1104434C Optical pure analogs of camptothecinum and composition and use thereof |
| 04/02/2003 | CN1104432C Pyrrole triazines and pyrimidine compound |
| 04/02/2003 | CN1104430C Angiogenesis inhibiting pyridazinamines |
| 04/02/2003 | CN1104428C Substitued benzocycloheptapyridine useful ad inhibitors of Farnesyl protein transferase |
| 04/02/2003 | CN1104427C Tricyclic inhibitors of farnesyl protein transferase |
| 04/02/2003 | CN1104422C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 04/02/2003 | CN1104421C Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/02/2003 | CN1104420C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl) phenyl)-4-methyl-2,5-imidazolidin-1-yl) acetylamino)-3-phenyl propionate |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/02/2003 | CN1104413C Phenylalkylcarboxylic acid derivatives |
| 04/02/2003 | CN1104412C Benzamidine derivatives and use thereof as medicaments with LTB4-antagonistic effect |
| 04/02/2003 | CN1104378C Fine cisplatin powder and process for production thereof |
| 04/02/2003 | CN1104257C Oesteoblast growth stimulating composition containing PDGF and vitamin D |
| 04/02/2003 | CN1104254C Medicinal liquid for treating bone fracture |
| 04/02/2003 | CN1104252C Health-care oil for reducing cholesterol and its preparing process |
| 04/02/2003 | CN1104250C Capsule for regeneration of heart valves |
| 04/02/2003 | CN1104246C Fumigant lotion for treating anorectal disease and preparing process thereof |
| 04/02/2003 | CN1104244C Use of physiologically acceptable vanadium compounds, salts and compelxes |
| 04/02/2003 | CN1104243C Use of aromatase inhibitors in prepn. of drug for treating relative androgend efficiency in men |
| 04/02/2003 | CN1104242C Use of epinastine in the treatment of pain |
| 04/02/2003 | CN1104241C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetraphdropyridine for preparing drugs for treating amyotrophic lateral scherosis |
| 04/02/2003 | CN1104240C Composition comprising amoxycillin and clavulanic acid, its preparation and use |
| 04/02/2003 | CN1104238C Enteric-coated pharmaceutical compositions of mycophenolate |
| 04/02/2003 | CN1104237C Use of omega-3 polyunsaturated acids |
| 04/02/2003 | CN1104236C 一种治疗胃病的口服液 A treatment for stomach oral |
| 04/02/2003 | CN1104235C Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans |
| 04/02/2003 | CN1104234C Carotenoid preparation capable of mixing with liquid and oil |
| 04/02/2003 | CN1104233C Spot-eliminating and beautifying cream |
| 04/02/2003 | CN1104231C Use of 1-hydroxy-2-pyridone for the treatment of seborrheic dermatitis |
| 04/02/2003 | CN1104202C Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing |
| 04/02/2003 | CA2424540A1 Propionic acid derivatives with ppar-alpha activating properties |
| 04/02/2003 | CA2405934A1 Means and method for the treatment of coronary artery obstructions |
| 04/01/2003 | US6542858 Pharmacokinetic-based drug design tool and method |
| 04/01/2003 | US6541680 Mixture of choline, betaine, folic acid, vitamin B12, methionine and zinc |
| 04/01/2003 | US6541672 Showing anti-bacterial, antioxidant, and anti-inflammatory activities that enable them to be used for drugs |
| 04/01/2003 | US6541670 Antiinflammatory agents |
| 04/01/2003 | US6541669 Multibinding amine compounds which are beta 2 adrenergic receptor agonists useful in treatment and prevention of respiratory diseases such as asthma, bronchitis |
| 04/01/2003 | US6541661 Inhibitors of histone deacetylase |
| 04/01/2003 | US6541649 Process for synthesis of novel cationic amphiphiles containing N-hydroxyalkyl group for intracellular delivery of biologically active molecules |
| 04/01/2003 | US6541646 Method of preparing COX-2 inhibitors |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541637 Reacting a paroxetine with hydrogen chloride in the presence of isopropyl alcohol and crystallizing the resulting product to form paroxetine hydrochloride anhydrate, drying to reduce amount of isopropyl alcohol to 5% |
| 04/01/2003 | US6541634 Process for preparing growth hormone secretagogues |
| 04/01/2003 | US6541629 Enzyme inhibitors |
| 04/01/2003 | US6541616 Exterior membrane; nucleotide sequence; induction immunology response |
| 04/01/2003 | US6541612 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 04/01/2003 | US6541523 Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine |
| 04/01/2003 | US6541522 Including longistyline A-2-carboxylic acid as a dietary supplement |
| 04/01/2003 | US6541520 Treatment of addiction and addiction-related behavior |
| 04/01/2003 | US6541519 Administering 12-methyltetradecanoic acid in an effective carrier for cancer therapy |
| 04/01/2003 | US6541518 Preventing pathogens in blood plasma and for enhancing the production of cryoprecipitate from plasma by adding a low molecular weight carboxylic acid or salt to the plasma, preferably trisodium citrate |
| 04/01/2003 | US6541517 Applying to the affected area of the skin an amount of a glyceryl fatty acid ester and an inert vehicle |
| 04/01/2003 | US6541514 Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids |
| 04/01/2003 | US6541513 Carbamate compounds for use in preventing or treating psychotic disorders |
| 04/01/2003 | US6541511 Treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders. |
| 04/01/2003 | US6541509 Method for treating neoplasia using combination chemotherapy |
| 04/01/2003 | US6541508 Water solubility; prodrug containing polyether oligomer |
| 04/01/2003 | US6541507 Notably 4,6-dimethoxyindole-2-carboxylic acid and derivatives thereof |
| 04/01/2003 | US6541506 Enediyne carboxylated on one end and having a pyrrole, furan or thiophene ring on the other; may be isolated from annarrhinum bellidofolium |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541503 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |
| 04/01/2003 | US6541502 Treatment of disorders associated with dopamine dysregulation such as schizophrenia |
| 04/01/2003 | US6541501 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 04/01/2003 | US6541499 Benzimidazole derivatives; e.g., 5-hydroxy-1-(3-methoxy-4-((1,2,4-triazol-1-yl)-methyl)benzyl) -2-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-benzimidazole |
| 04/01/2003 | US6541498 Benzenesulfonamides and the use thereof to modulate the activity of endothelin |
| 04/01/2003 | US6541496 Inhibitors of IMPDH enzyme |
| 04/01/2003 | US6541493 Type A, B, C and D crystals of said compound; excellent in stability, and has advantages in handling, storage, and pharmaceutical preparation. |
| 04/01/2003 | US6541492 Thiazole derivatives as PPAR gamma ligands |
| 04/01/2003 | US6541491 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 04/01/2003 | US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541488 Compositions for treating arterial thrombosis and a factor Xa inhibitor |
| 04/01/2003 | US6541487 Administering 5-bromoquinoline, 5-nitroisoquinoline, 8-nitroisoquinoline, 3,4-dihydro-6-hydroxy-2(1H)-quinolone or 1-methylisoquinoline to relax corpus cavernosa smooth-muscle tissue in males or females |
| 04/01/2003 | US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation. |
| 04/01/2003 | US6541485 Urea substituted imidazoquinolines |
| 04/01/2003 | US6541484 Central nervous system disorders; psychological disorders |
| 04/01/2003 | US6541483 Acridone-derived compounds useful as antineoplastic and antiretroviral agents |
| 04/01/2003 | US6541482 Autoimmune disease |
| 04/01/2003 | US6541481 Substituted bicyclic derivatives useful as anticancer agents |
| 04/01/2003 | US6541478 Smoking cessation treatments using naltrexone and related compounds |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541476 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/01/2003 | US6541475 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541473 Resorcinol derivatives |
| 04/01/2003 | US6541472 Compounds, compositions and methods for preventing and treating pestivirus infection and associated diseases |
| 04/01/2003 | US6541471 Useful as a TXA2 receptor antagonist and a 5-HT2 receptor antagonist |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 04/01/2003 | US6541469 CRF receptor antagonists and methods relating thereto |
| 04/01/2003 | US6541468 Treating Alzheimer's disease by inhibiting in a subject hyperphosphoralation characteristic of Alzheimer's disease by a kinase the compound |
| 04/01/2003 | US6541466 Such as 1-(N'-(3,5-difluorophenylacetyl)-L-alaninyl)-aminodibenzosuberane; for treatment of Alzheimer's disease |
| 04/01/2003 | US6541465 Orally active androgens |